More specifically, five HML-2-encoded differentially expressed genes and ten HML-2-encoded sRNAs have been described that participate in the immunological processes and the progression of SLE and lupus-nephritis-mediated tissue injury, several of which have been validated through qRT-PCR in SLE patients. This evidence concerns the gene CLEC10A and systemic lupus erythematosus.